Concepts and issues with interspecies scaling in zoological pharmacology

Journal of Zoo and Wildlife Medicine

Volumn 39, Issue 4, 2008, Pages 517-526

  Hunter, Robert P ^a   Isaza, Ramiro ^b  

^a ELANCO ANIMAL HEALTH   (United States)

^b University of Florida   (United States)

Author keywords

Allometric scaling; Drug metabolism; Interspecies scaling; Pharmacokinetics; Veterinary pharmacology; Zoologic pharmacology

Indexed keywords

VETERINARY DRUG;

ANIMAL; BODY WEIGHT; DOSE RESPONSE; DRUG EFFECT; DRUG LEGISLATION; ENVIRONMENTAL PROTECTION; LAW; METABOLIC CLEARANCE RATE; METABOLISM; PHYSIOLOGY; REVIEW; SPECIES DIFFERENCE; ZOO ANIMAL;

ANIMALS; ANIMALS, ZOO; BODY WEIGHT; CONSERVATION OF NATURAL RESOURCES; DOSE-RESPONSE RELATIONSHIP, DRUG; LEGISLATION, DRUG; LEGISLATION, VETERINARY; METABOLIC CLEARANCE RATE; SPECIES SPECIFICITY; VETERINARY DRUGS;

ANIMALIA;

EID: 58149109212     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: 10.1638/2008-0041.1     Document Type: Review

References (99)

1. Adolph, E. F. 1949. Quantitative relations in the physiological constitutions of mammals. Science 109: 579-585.
2. Anderson, B. J., and N. H. G. Holford. 2008. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu. Rev. Pharmacol. Toxicol. 48: 303-332.
3. Baggot, J. D., and Q. A. McKellar. 1994. The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics. J. Vet. Pharmacol. Therap. 17: 409-419.
4. Benedict, F. G. 1938. Vital Energetics A Study in Comparative Basal Metabolism. Carnegie Institution of Washington, Washington, D.C. Pp. 3-215.
5. Bermingham, E. C., and M. G. Papich. 2002. Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep. Am. J. Vet. Res. 63: 1012-1017.
6. Boeckh, A., D. Boothe, S. Wilkie, and S. Jones. 2001. Time course of enrofloxacin and its active metabolite in peripheral leukocytes of dogs. Vet. Therap. 2: 334-344.
7. Boxenbaum, H. 1980. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin. J. Pharmacokinet. Biopharm. 8: 165-176.
8. Boxenbaum, H. 1982. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J. Pharmacokinet. Biopharm. 10: 201-227.
9. Boxenbaum, H., and C. DiLea. 1995. First-time-inhuman dose selection: allometric thoughts and perspectives. J. Clin. Pharmacol. 35: 957-966.
10. Boxenbaum, H., and R. Ronfeld. 1983. Interspecies pharmacokinetic scaling and the Dedrick plots. Am. J. Physiol. 245: R768-R774.
11. Bregante, M. A., P. Saez, J. J. Aramayona, L. Fraile, M. A. Garcia, and C. Solans. 1999. Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. Am. J. Vet. Res. 60: 1111-1116.
12. Brodie, B. B., and W. D. Reid. 1967. Some pharmacological consequences of species variation in rates of metabolism. Fed. Proc. 26: 1062-1070.
13. Broome, R. L., D. L. Brooks, J. G. Babish, D. D. Copeland, and G. M. Conzelman. 1991. Pharmacokinetic properties of enrofloxacin in rabbits. Am. J. Vet. Res. 52: 1835-1841.
14. Calder, W. A. 1981. Scaling of physiological processes in homeothermic animals. Ann. Rev. Physiol. 43: 301-322.
15. Castells, G., B. P. S. Capece, F. Pérez, G. Martí, M. Arboix, and C. Cristòfol. 2001. Allometric analysis of thiamphenicol disposition among seven mammalian species. J. Vet. Pharmacol. Therap. 24: 193-197.
16. Chaui-Berlinck, J. G. 2006. A critical understanding of the fractal model of metabolic scaling. J. Exp. Biol. 209: 3045-3054.
17. Chiu, S.-H. L., and S.-U. W. Huskey. 1998. Species differences in N-glucuronidation. Drug Metab. Disp. 26: 838-847.
18. Cox, S. K., M. B. Cottrell, L. Smith, M. G. Papich, D. L. Frazier, and J. Bartges. 2004. Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across species. J. Vet. Pharmacol. Therap. 27: 139-146.
19. Dalvi, R. R., V. A. Nunn, and J. Juskevich. 1987. Hepatic cytochrome P-450 dependent drug metabolizing activity in rats, rabbits and several food producing species. J. Vet. Pharmacol. Therap. 10: 164-168.
20. Darveau, C.-A., R. K. Suarez, R. D. Andrews, and P. W. Hochachka. 2002. Allometric cascade as a unifying principle of body mass effects on metabolism. Nature 417: 166-170.
21. Dedrick, R. L. 1974. Animal scale-up. In: Teorell, T., R. L. Dedrick, and P. G. Cundliffe (eds.). Pharmacology and Pharmacokinetics. Plenum Press, New York, New York. Pp. 117-144.
22. Dedrick, R. L., and K. B. Bischoff. 1980. Species similarities in pharmacokinetics. Fed. Proc. 39: 54-59.
23. Dedrick, R. L., K. B. Bischoff, and D. S. Zaharko. 1970. Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother. Rep. 54: 95-101.
24. Dedrick, R. L., D. D. Forrester, J. N. Cannon, S. M. Dareer, and L. B. Mellett. 1973. Pharmacokinetics of 1-®-d-arabino-furanosylcytosine (ARA-C) deamination in several species. Biochem. Pharmac. 22: 2405-2417.
25. DeMarco, J. H., D. J. Heard, G. J. Fleming, B. A. Lock, and T. J. Scase. 2002. Ivermectin toxicosis after topical administration in dog-faced fruit bats (Cynopterus brachyotis). J. Zoo Wild. Med. 33: 147-150.
26. Dorrestein, G. M. 2000. Quick reference for drug dosing. In: Tully, T. N., M. P. C. Lawton, and G. M. Dorrestein (eds.). Avian Medicine. Butterworth Heinemann, Oxford, United Kingdom. Pp. 386-390.
27. Downes, H. 2002. Relative metabolic rate as a basis for extrapolation of drug-elimination times from mammals to frogs. J. Herp. Med. Surg. 12: 4-11.
28. Edwards, N. A. 1975. Scaling of renal functions in mammals. Comp. Biochem. Physiol. 52A: 63-66.
29. Gamble, K. C., D. M. Boothe, J. M. Jensen, J. J. Heatley, and K. E. Helmick. 1997. Pharmacokinetics of a single intravenous enrofloxacin dose in scimitar-horned oryx (Oryx dammah). J. Zoo Wild. Med. 28: 36-42.
30. Gamble, K. C., J. M. Jensen, D. M. Boothe, J. J. Heatley, and K. E. Helmick. 1995. Pharmacokinetics of amikacin in scimitar-horned oryx (Oryx dammah) from a single intravenous dose. J. Zoo Wild. Med. 26: 359-366.
31. Graham, M. J., A. R. Bell, H. K. Crewe, C. L. Moorcraft, L. Walker, E. F. Whittaker, and M. S. Lennard. 2003. mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates. Xenobiotica 33: 225-237.
32. Gulland, F. M., M. K. Stoskopf, S. P. Johnson, J. Riviere, and M. G. Papich. 2000. Amoxicillin pharmacokinetics in harbor seals (Phoca vitulina) and northern elephant seals (Mirounga angustirostris) following single dose intravenous administration: implications for interspecific dose scaling. J. Vet. Pharmacol. Therap. 23: 223-228.
33. Hayton, W. L. 1989. Pharmacokinetic parameters for interspecies scaling using allometric techniques. Health Physics 57: 159-164.
34. Hennessy, D. R. 1994. The disposition of antiparasitic drugs in relation to the development of resistance by parasites of livestock. Acta Tropica 56: 125-141.
35. Hinchcliff, K. W., A. D. Jemigan, and P. D. Constable. 1991. Ruminant pharmacology. Vet. Clin. N. Am. Food Anim. Pract. 7: 633-649.
36. Holt, J. P., and E. Rhode. 1976. Similarity of renal glomerular hemodynamics in mammals. Am. Heart J. 92: 465-472.
37. Hopper, K., J. Aldrich, and S. C. Haskins. 2002. Ivermectin toxicity in 17 collies. J. Vet. Intern. Med. 16: 89-94.
38. Hunter, R. P., R. Isaza, and D. E. Koch. 2003. Oral bioavailability and pharmacokinetic characteristics of ketoprofen enantiomers after oral and intravenous administration in Asian elephants (Elephas maximus). Am. J. Vet. Res. 64: 109-114.
39. Hunter, R. P., I. Mahmood, and M. N. Martinez. 2008. Prediction of xenobiotic clearance in avian species using mammalian data: how accurate is the prediction? J. Vet. Pharmacol. Therap. 31: 281-284.
40. Jacobson, E. R. 1996. Metabolic scaling of antibiotics in reptiles: basis and limitations. Zoo Biol. 15: 329-339.
41. Jezequel, S. G. 1994. Fluconazole: interspecies and allometric relationships of pharmacokinetic properties. J. Pharm. Pharmacol. 46: 196-199.
42. Kararli, T. T. 1989. Gastrointestinal absorption of drugs. CRC Crit. Rev. Therap. Drug Carr. Sys. 6: 39-86.
43. Kirkwood, J. K., and J. Merriam. 1990. Variation in plasma half-life of gentamicin between species in relation to body weight and taxonomy. Res. Vet. Sci. 49: 160-165.
44. Kleiber, M. 1932. Body size and metabolism. Hilgarida 6: 315-353.
45. Kleiber, M. 1961. The Fire of Life. An Introduction to Animal Energetics. Wiley, New York, New York.
46. Kumar, N., S. D. Singh, and C. Jayachandran. 2003. Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin and its interaction with diclofenac after intravenous administration in buffalo calves. Vet. J. 165: 302-306.
47. Küng, K. J.-L. Riond, and M. Wanner. 1993. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J. Vet. Pharmacol. Therap. 16: 462-468.
48. Landoni, M. E, and P. Lees. 1995. Influence of formulation on the pharmacokinetics and bioavailability of racemic ketoprofen in horses. J. Vet. Pharmacol. Therap. 18: 446-450.
49. Landoni, M. F., and P. Lees. 1996. Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in the horse. J. Vet. Pharmacol. Therap. 19: 466-474.
50. Lankford, S. M., S. A. Bai, and J. A. Goldstein. 2000. Cloning of canine cytochrome P450 2E1 cDNA: identification and characterization of two variant alleles. Drug Metab. Disp. 28: 981-986.
51. Lanusse, C. E., and R. K. Prichard. 1993. Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics. Vet. Parasitol. 49: 123-158.
52. Lees, P., and F. S. Aliabadi. 2002. Rational dosing of antimicrobial drugs: animals versus humans. Int. J. Antimicrob. Agents 19: 269-284.
53. Lindstedt, S. L., and P. J. Schaeffer. 2002. Use of allometry in predicting anatomical and physiological parameters of mammals. Lab. Anim. 36: 1-19.
54. Locke, D., M. Bush, and J. W. Carpenter. 1982. Pharmacokinetics and tissue concentrations of tylosin in selected avian species. Am. J. Vet. Res. 43: 1807-1810.
55. Mahmood, I. 2007. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development. Adv. Drug Del. Rev. 59: 1177-1192.
56. Mahmood, I., and J. D. Balian. 1999. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols. Clin. Pharmacokinet. 36: 1-11.
57. Mahmood, I., M. D. Green, and J. E. Fisher. 2003. Selection of the first-time dose in humans: comparison of different approaches based on interspecies scaling of clearance. J. Clin. Pharmacol. 43: 692-697.
58. Mahmood, I., M. Martinez, and R. P. Hunter. 2006. Interspecies allometric scaling. Part I: prediction of clearance in large animals. J. Vet. Pharmacol. Therap. 29: 415-423.
59. Martín-Jiménez, T., and J. E. Riviere. 2001. Mixed effects modeling of the disposition of gentamicin across domestic animal species. J. Vet. Pharmacol. Therap. 24: 321-332.
60. Martinez, M. N. 2005. Interspecies differences in physiology and pharmacology: extrapolating preclinical data to human populations. In: Rogge, M., and D. Taft (eds.). Preclinical Drug Development. Marcel Dekker, New York, New York. Pp. 11-66.
61. Martinez, M., I. Mahmood, and R. P. Hunter. 2006. Interspecies allometric scaling: prediction of clearance in large animal species: Part II: mathematical considerations. J. Vet. Pharmacol. Therap. 29: 425-432.
62. Martinez, M. N., W. M. Pedersoli, W. R. Ravis, J. D. Jackson, and R. Cullison. 2001. Feasibility of interspecies extrapolation in determining the bioequivalence of animal products intended for intramuscular administration. J. Vet. Pharmacol. Therap. 24: 125-135.
63. Mealey, K. L., S. A. Bentjen, J. M. Gay, and G. H. Cantor. 2001. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 11: 727-733.
64. Mengozzi, G., L. Intorre, S. Bertini, and G. Soldani. 1996. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep. Am. J. Vet. Res. 57: 1040-1043.
65. Mordenti, J. 1986. Man versus beast: pharmacokinetic scaling in mammals. J. Pharm. Sci. 75: 1028-1040.
66. Morris, T. H. 1999. Dosage estimation among species. In: Hawk, C. T., and S. L. Leary (eds.). Formulary for Laboratory Animals, 2nd ed. Iowa State University Press, Ames, Iowa. Pp. 3-12.
67. Mortenson, J. 2001. Determining dosages for antibiotic and anti-inflammatory agents. In: Csuti, B., E. L. Sargent, and U. S. Bechert (eds.). The Elephant's Foot: Prevention and Care of Foot Conditions in Captive Asian and African Elephants. Iowa State University Press, Ames, Iowa. Pp. 141-144.
68. Owens, J. G., S. G. Kamerling, and S. A. Barker. 1995. Pharmacokinetics of ketoprofen in healthy horses and horses with acute synovitis. J. Vet. Pharmacol. Therap. 18: 187-195.
69. Page, C. D., M. Mautino, H. D. Derendorf, and J. P. Anhalt. 1991. Comparative pharmacokinetics of trimethoprim-sulfamethoxazole administered intravenously and orally to captive elephants. J. Zoo Wild. Med. 22: 409-416.
70. Paulson, S. K., L. Engel, B. Reitz, S. Bolten, E. G. Burton, T. J. Maziasz, B. Yan, and G. L. Schoenhard. 1999. Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metab. Disp. 27: 1133-1142.
71. Pearce, R., D. Greenway, and A. Parkinson. 1992. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch. Biochem. Biophys. 298: 211-225.
72. Plumb, D. C. 2005. Ivermectin. In: Veterinary Drug Handbook, 5th ed. Iowa State University Press, Ames, Iowa. Pp. 433-437.
73. Post, L. O., C. V. Cope, D. E. Farrell, J. D. Baker, and M. J. Myers. 2002. Influence of porcine ActinobacilIus pleuropneumoniae infection and dexamethasone on the pharmacokinetic parameters of enrofloxacin. J. Pharmacol. Exp. Therap. 301: 217-222.
74. Prescott, J. F. 2000. Aminoglycosides and aminocyclitols. In: Prescott, J. F., J. D. Baggot, and R. D. Walker (eds.). Antimicrobial Therapy in Veterinary Medicine, 3rd ed. Iowa State University Press, Ames, Iowa. Pp. 191-228.
75. Rahal, A., A. Kumar, A. H. Ahmad, J. K. Malik, and V. Ahuja. 2006. Pharmacokinetics of enrofloxacin in sheep following intravenous and subcutaneous administration. J. Vet. Pharmacol. Therap. 29: 321-324.
76. Rao, G. S., S. Ramesh, A. H. Ahmad, H. C. Tripathi, L. D. Sharma, and J. K. Malik. 2002. Disposition kinetics of enrofloxacin and ciprofloxacin following intravenous administration of enrofloxacin in goats. Small Rumin. Res. 44: 9-15.
77. Riviere, J. E. 1999. Interspecies extrapolations. In: Comparative Pharmacokinetics: Principles, Techniques, and Applications. Iowa State University Press, Ames, Iowa. Pp. 296-307.
78. Riviere, J. E., T. Martin-Jimenez, S. F. Sundlof, and A. L. Craigmill. 1997. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species. J. Vet. Pharmacol. Therap. 20: 453-463.
79. Sagara, K., H. Mizuta, M. Ohshiko, M. Shibata, and K. Haga. 1995. Relationship between the phasic period of interdigestive migrating contraction and the systemic bioavailability of acetaminophen in dogs. Pharm. Res. 12: 594-598.
80. Sams, R., D. F. Gerken, and S. M. Ashcraft. 1995. Pharmacokinetics of ketoprofen after multiple intravenous doses to mares. J. Vet. Pharmacol. Therap. 18: 108-116.
81. Schinkel, A. H., J. J. M. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. J. te Riele, A. J. M. Berns, and P. Borst. 1994. Disruption of the mouse mdrla p-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491-502.
82. Schmidt-Nielsen, K. 1975. Scaling in biology: the consequences of size. J. Exp. Zool. 194: 287-308.
83. Schmidt-Nielsen, K. 1984. Scaling: Why Body Size Is So Important? Cambridge Univ. Press, Cambridge, New York.
84. Sedgwick, C. J. 1993. Allometric scaling and emergency care: the importance of body size. In: Fowler, M. E. (ed.). Zoo and Wild Animal Medicine, 3rd ed. W. B. Saunders, Philadelphia, Pennsylvania. Pp. 34-37.
85. Sedgwick, C. J., and R. Borkowski. 1996. Allometric scaling: extrapolating treatment regimens for reptiles. In: Mader, D. R. (ed.). Reptile Medicine and Surgery. W. B. Saunders, Philadelphia, Pennsylvania. Pp. 235-241.
86. Sharma, P. K., A. H. Ahmad, L. D. Sharma, and R. Varma. 2003. Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves. Vet. J. 166: 101-104.
87. Short, C. R. 1994. Consideration of sheep as a minor species: comparison of drug metabolism and disposition with other domestic ruminants. Vet. Human Toxicol. 36: 24-40.
88. Short, C. R. 1999. Comparative pharmacokinetics - sorting the sheep from the goats. Vet. J. 158: 159-161.
89. Short, C. R., W. Flory, and M. Flynn. 1988. Hepatic drug metabolizing enzyme activity in the channel catfish, Ictalurus punctatus. Comp. Biochem. Physiol. 89C: 153-157.
90. Short, C. R., W. Flory, L. C. Hsieh, and S. A. Barker. 1988. The oxidative metabolism of fenbendazole: a comparative study. J. Vet. Pharmacol. Therap. 11: 50-55.
91. Short, C. R., W. Flory, L. C. Hsieh, T. Arenas, S.-P. Ou, and J. Weissinger. 1988. Comparison of hepatic drug metabolizing enzyme activities in several agricultural species. Comp. Biochem. Physiol. 91C: 419-424.
92. Singer, M. A. 2001. Of mice and men and elephants: metabolic rate sets glomerular filtration rate. Am. J. Kidney Dis. 37: 164-178.
93. Smith, D. A. 1991. Species differences in metabolism and pharmacokinetics: are we close to an understanding? Drug Metab. Rev. 23: 355-373.
94. Souhaili-El Amri, H., A. M. Batt, and G. Siest. 1986. Comparison of cytochrome P-450 content and activities in liver microsomes of seven animal species, including man. Xenobiotica 16: 351-358.
95. Széll, Z., T. Sréter, and I. Varga. 2001. Ivermectin toxicosis in a chameleon (Chamaeleo senegalensis) infected with Foleyella furcata. J. Zoo Wild. Med. 32: 115-117.
96. Teare, J. A., and M. Bush. 1983. Toxicity and efficacy of ivermectin in chelonians. J. Am. Vet. Med. Assoc. 183: 1195-1197.
97. Tranquilli, W. J., A. J. Paul, and R. L. Seward. 1989. Ivermectin plasma concentrations in collies sensitive to ivermectin-induced toxicosis. Am. J. Vet. Res. 50: 769-770.
98. Verde, C. R., M. I. Simpson, A. Frigoli, and M. F. Landoni. 2001. Enantiospecific pharmacokinetics of ketoprofen in plasma and synovial fluid of horses with acute synovitis. J. Vet. Pharmacol. Therap. 24: 179-185.
99. West, L. J., C. M. Pierce, and W. D. Thomas. 1962. Lysergic acid diethylamide: its effects on a male asiatic elephant. Science 138: 1100-1103.